Michael Narachi
Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Equibles does not estimate personal net worth.
Get an email with a short summary when Ultragenyx Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.
Get RARE alertsAbout Michael Narachi
Michael Narachi is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE). The newest filing on record that lists Michael Narachi as Board Member at Ultragenyx Pharmaceutical Inc. (RARE) is dated April 29, 2020. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed June 21, 2024 that Michael Narachi was appointed Class II Director, effective June 18, 2024. Ultragenyx Pharmaceutical Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ultragenyx Pharmaceutical Inc. includes Emil D. Kakkis (CEO and Board Member), Emil Kakkis (CEO and Board Member), Howard Horn (CFO) and 7 others.
“At the Annual Meeting, the Company's stockholders elected the Class II director nominees below to the Company's Board of Directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are elected.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 29, 2020
Company network
Leadership on record at Ultragenyx Pharmaceutical Inc.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member